933733-10-9

Basic information

• Product Name: (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene
• Synonyms: (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene
• CAS NO: 933733-10-9
• Molecular Weight: 235.326
• Mol File: 933733-10-9.mol

Chemical Properties

• CAS DataBase Reference: (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene(933733-10-9)
• EPA Substance Registry System: (-)-cis-1,2-dimethoxy-4-(2-amino-cyclohexyl)benzene(933733-10-9)

Safety Data

• Hazardous Substances Data: 933733-10-9(Hazardous Substances Data)

Upstream product

• 189831-00-3 (+/-)-cis-1,2-dimethoxy-4-(2-nitrocyclohexyl)benzene 
• 7440-66-6 zinc 
• 121-44-8 triethylamine 
• 4230-93-7 3,4-dimethoxynitrostyrene 

Relevant articles and documents

Substituted tetrahydroisoquinoline compounds, methods of making, and their use

The present invention relates to novel substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing the compounds, methods of making the compounds, and methods of using the compounds to destroy a target cell, such as a cancer cell,

Novel 6-heteroarylphenanthridines

Compounds of the formula I, in which Het is an unsubstituted or R6-and/or R7-sustituted pyrrolyl, furanyl, thiophenyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrimidinyl, pyrazinyl or pyridazinyl radical, or an

Phenanthridine-n-oxides

N-oxides of the compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy

Phenanthridine-N-oxides with PDE-IV inhibiting activity

The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are novel active bronchial therapeutics.

Tetrazole derivatives

Compounds of formula I, in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, are efficacious bronchial therapeutics.

Phenanthridine-n-oxides with pde-iv inhibiting activity

The N-oxides of the compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated in the description, arm novel active bronchial therapeutics.

Phenylphennanthridines with PDE-IV inhibiting activity

Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51, R6, R13 and R20 have the meaning indicated in the description, are novel active bronchial therapeutics

6-arylphenanthridines with PDE-IV inhibiting activity

Compounds of formula (I), in which R1, R2, R3, R31, R4, R5, R51 and Ar have the meanings indicated in the description, are novel active bronchial therapeutics.

Phenanthridines

Compounds of formula (I), where R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings given in the description, are new active bronchial therapeutic agents.

Phenanthridines substituted in the 6 position

PCT No. PCT/EP97/01487 Sec. 371 Date Sep. 3, 1998 Sec. 102(e) Date Sep. 3, 1998 PCT Filed Mar. 24, 1997 PCT Pub. No. WO97/35854 PCT Pub. Date Oct. 2, 1997Compounds of the formula I in which R1, R2, R3, R31, R4, R5, R51 and R6 have the meanings indicated i